Novo Nordisk's diet drug Wegovy oral tablets were approved by the European Commission and became the EU's first oral GLP‑1 drug for weight management; its 7.2 mg high-dose disposable ready-to-use syringe was approved at the same time.

Novo Nordisk's diet drug Wegovy oral tablets were approved by the European Commission and became the EU's first oral GLP‑1 drug for weight management; its 7.2 mg high-dose disposable ready-to-use syringe was approved at the same time.